Kaitlyn Bader, Assistant Managing Editor

Linda Stein Gold, MD, FAAD, discusses the late-breaking tapinarof cream data presented at AAD 2025.

Raj Chovatiya, MD, PhD, MSCI, discusses how early-career dermatologists can gain the most benefit from this year’s annual meeting.

Jeanine Downie, MD, FAAD, discussed critical updates on tattoo ink safety, new dermatologic technologies, biostimulators, and more at AAD 2025.

Patrick Burnett, MD, PhD, shares key updates expected in 2025 for therapeutics treating atopic dermatitis, alopecia areata, and more.

Experts discussed personalized approaches to atopic dermatitis, from steroid-sparing topicals to biologics, highlighting rapid relief and long-term management strategies.

At a recent Dermatology Times Case-Based Roundtable event, James Q. Del Rosso, DO, discussed the limitations of topical corticosteroids and the benefits of nonsteroidals.

The overwhelmingly positive feedback from both clinicians and patients reinforces the unmet need roflumilast foam is addressing in seborrheic dermatitis care.

Barbieri et al evaluated product use, benzoyl peroxide concentration, days until expiration, and more.

Alexandra Golant, MD, led a Dermatology Times Case-Based Roundtable® event that focused on advancing therapeutic strategies for atopic dermatitis.

Nektar Therapeutics’ investigational biologic targets the IL-2 receptor complex.

At the Horizons in Advanced Practice meeting, Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP, presented a case of a woman aged 35 years with widespread eczematous lesions covering over 50% BSA and severe lichenification.

Pilot and research grants may be awarded to research on keratinocyte biology and differentiation, genetics, biology of skin inflammation, itch, or other ichthyosis-related areas.

The Pillars of Confidence global study assessed the role that confidence plays in daily life and how aesthetic treatments affect confidence.

At the Horizons in Advanced Practice meeting, Douglas DiRuggiero, DMSc, MHS, PA-C, presented a case of a man aged 47 years with a history of moderate psoriasis for 3 years and a recent diagnosis of psoriatic arthritis

At the Horizons in Advanced Practice meeting, Omar Noor, MD, FAAD, presented a case of a man aged 70 years with a 20-year history of psoriasis who was previously treated with adalimumab.

Renata Block, MMS, PA-C, and Erica Ramos, PA-C, discuss the complexities of developing an over-the-counter hair product.

At the inaugural Horizons in Advanced Practice meeting, Douglas DiRuggiero, DMSc, MHS, PA-C, discussed how NPs and PAs can advance their professional growth by seizing opportunities to share their clinical experiences.

Renata Block, MMS, PA-C, interviewed Erica Ramos, PA-C, the founder of RestoraScalp medicated dry shampoo.

Shanna Miranti, MPAS, PA-C, discusses the Umary hyaluronic acid tablets that were recalled in fall 2024.

At the inaugural Horizons in Advanced Practice meeting, Lakshi Aldredge, MSN, ANP-BC, reviewed complex cases on AD and PsO and the role of PAs and NPs in advancing patient care.

As 2024 comes to a close, Dermatology Times is taking a look back at the unique insights and updates shared by nurse practitioners and physician assistants.

At the inaugural Horizons in Advanced Practice meeting, Dr. Noor highlighted the value of amplifying the voices of physician assistants and nurse practitioners to advance patient care.

Experts highlight the versatility and patient-centered approach of PDT with red light, emphasizing its effectiveness for AK, skin rejuvenation, and superficial cancers.

Discover 2024 skin cancer breakthroughs, including FDA approvals, innovative therapies, and updated clinical guidelines for melanoma and nonmelanoma care.

Review some of the top highlights shared at physician assistant and nurse practitioner dermatology meetings in 2024.

Catch up on exclusive interviews with Shanna Miranti, MPAS, PA-C; Renata Block, MMS, PA-C; Jane Mast, PhD, DMSc, MPAS; PA-C; Sara Wilchowski, DMSc, MPAS, PA-C; and Michael Rubio, PA-C, from the 2024 SDPA Fall Conference.

The exclusive event brought together physician assistants and nurse practitioners from across the country to review atopic dermatitis and psoriasis patient cases.

Treatment with delgocitinib led to a significant decrease in the expression of inflammatory markers that were elevated in severe cases compared with mild cases at baseline.

Read more about acne treatment tips shared at the 2024 SDPA Fall Conference by experts such as Shanna Miranti, MPAS, PA-C, and Hilary Baldwin, MD.

Catch up on coverage from the 22nd annual Society of Dermatology Physician Associates Fall Dermatology Conference in Las Vegas, Nevada.